PDL BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PDL BioPharma and buy or sell other stocks, ETFs, and their options commission-free!About PDLI
PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments.
CEOChristopher Lewis Stone
CEOChristopher Lewis Stone
Employees—
Employees—
HeadquartersReno, Nevada
HeadquartersReno, Nevada
Founded1986
Founded1986
Employees—
Employees—
PDLI Key Statistics
Market cap233.85M
Market cap233.85M
Price-Earnings ratio-1.81
Price-Earnings ratio-1.81
Dividend yield—
Dividend yield—
Average volume6.15M
Average volume6.15M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.52
52 Week high$2.52
52 Week low$1.61
52 Week low$1.61
Stock Snapshot
PDL BioPharma(PDLI) stock is priced at $2.47, giving the company a market capitalization of 233.85M. It carries a P/E multiple of -1.81.
PDL BioPharma(PDLI) stock opened on 2025-11-05 at —. The price climbed to — and dipped to —.
The PDL BioPharma(PDLI)'s current trading volume is 0, compared to an average daily volume of 6.15M.
In the last year, PDL BioPharma(PDLI) shares hit a 52-week high of $2.52 and a 52-week low of $1.61.
In the last year, PDL BioPharma(PDLI) shares hit a 52-week high of $2.52 and a 52-week low of $1.61.
People also own
Based on the portfolios of people who own PDLI. This list is generated using Robinhood data, and it’s not a recommendation.